Relief of gastrointestinal symptoms under enzyme replacement therapy in patients with Fabry disease

By Dehout F.   Roland D.   de Granseigne S.   Guillaume B.   Van Maldergem L.  

Journal of Inherited Metabolic Disease, Vol. 27, Iss. 4, 2004-07 ,pp. : 499-505

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring enzyme replacement therapy in Fabry disease—Role of urine globotriaosylceramide

By Whitfield P.   Calvin J.   Hogg S.   O’Driscoll E.   Halsall D.   Burling K.   Maguire G.   Wright N.   Cox T.   Meikle P.   Deegan P.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 1, 2005-01 ,pp. : 21-33

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring the clinical and biochemical response to enzyme replacement therapy in three children with Fabry disease

By Mills Kevin   Vellodi Ashok   Morris Peter   Cooper Donald   Morris Michael   Young Elisabeth   Winchester Bryan  

European Journal of Pediatrics, Vol. 163, Iss. 10, 2004-10 ,pp. : 595-603

Springer Publishing Company

Access to resources Recommend Favorite

Enzyme replacement therapy in Japanese Fabry disease patients: The results of a phase 2 bridging study

By Eto Y.   Ohashi T.   Utsunomiya Y.   Fujiwara M.   Mizuno A.   Inui K.   Sakai N.   Kitagawa T.   Suzuki Y.   Mochizuki S.   Kawakami M.   Hosoya T.   Owada M.   Sakuraba H.   Saito H.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 4, 2005-06 ,pp. : 575-583

Springer Publishing Company

Access to resources Recommend Favorite

CNS involvement in Fabry disease: Clinical and imaging studies before and after 12 months of enzyme replacement therapy

By Jardim L.   Vedolin L.   Schwartz I. V. D.   Burin M. G.   Cecchin C.   Kalakun L.   Matte U.   Aesse F.   Pitta-Pinheiro C.   Marconato J.   Giugliani R.  

Journal of Inherited Metabolic Disease, Vol. 27, Iss. 2, 2004-01 ,pp. : 229-240

Springer Publishing Company

Access to resources Recommend Favorite